{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-291024","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.828864+00:00","generated_at":"2026-06-28T23:18:53.931537+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bio-Rad's EVP President of Life Science Group Annette Tumolo to retire Jan 4, 2022","bullets":["Annette Tumolo, EVP President of Life Science Group and named executive officer, to retire effective Jan 4, 2022.","Tumolo served Bio-Rad for nearly 33 years before announcing retirement.","Company has initiated a search for a successor to Tumolo."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-291024","json":"https://secwatch.observer/filing/0001193125-21-291024.json","markdown":"https://secwatch.observer/filing/0001193125-21-291024.md","text":"https://secwatch.observer/filing/0001193125-21-291024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000119312521291024/0001193125-21-291024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000119312521291024/d238894d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:18:53.931537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6e518fceb6","claim":"Annette Tumolo departed as Executive Vice President, President, Life Science Group at BIO-RAD LABORATORIES, INC..","evidence_excerpt":"On September 28, 2021, Annette Tumolo, the Executive Vice President, President, Life Science Group, of Bio-Rad Laboratories, Inc. (the “Company”) and a named executive officer of the Company, informed the Company of her intention to retire from her position at the Company, effective January 4, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000119312521291024/0001193125-21-291024-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Executive Vice President, President, Life Science Group"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}